Veritable’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50,651
| Closed | -$420K | – | 647 |
|
|
2023
Q2 | $420K | Hold |
50,651
| – | – | 0.01% | 590 |
|
|
2023
Q1 | $223K | Hold |
50,651
| – | – | ﹤0.01% | 794 |
|
|
2022
Q4 | $299K | Buy |
50,651
+46,296
| +1,063% | +$273K | 0.01% | 660 |
|
|
2022
Q3 | $31K | Hold |
4,355
| – | – | ﹤0.01% | 784 |
|
|
2022
Q2 | $63K | Hold |
4,355
| – | – | ﹤0.01% | 867 |
|
|
2022
Q1 | $164K | Hold |
4,355
| – | – | ﹤0.01% | 871 |
|
|
2021
Q4 | $340K | Buy |
+4,355
| New | +$340K | 0.01% | 678 |
|